Streetbeat News

Revenues

TTWO

Take-Two Interactive (NASDAQ:TTWO) has been analyzed by 9 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $189.33, with a high of $200.00 and a low of $179.00. Analysts have maintained or raised their ratings, reflecting positive sentiment. Financially, Take-Two shows revenue growth but faces challenges with net margin and ROA.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 1:00 pm

MGX

In the past three months, four analysts have provided ratings on Metagenomi (NASDAQ:MGX), with a mix of bullish and somewhat bullish sentiments. The average 12-month price target is $12.25, down from a previous $14.75. Analysts have adjusted their ratings and price targets in response to market conditions, with some lowering their targets. Metagenomi, a genetic medicines company, has shown significant revenue growth but lags behind industry peers. The company maintains a strong financial position with effective debt management.

Portfolio Pulse from Benzinga Insights

August 21, 2024 | 1:00 pm

GS

MS

Goldman Sachs warns that upcoming US jobs data may overstate economic weakness, potentially impacting financial markets, including cryptocurrencies. The Bureau of Labor Statistics is set to release revised nonfarm payroll data, which could show slower job growth than initially reported. Morgan Stanley predicts a significant downward revision, possibly reigniting recession fears and affecting risk assets like Bitcoin. Goldman Sachs suggests the revisions may not fully reflect the true state of the job market.

Portfolio Pulse from Murtuza Merchant

August 21, 2024 | 12:46 pm

M

Macy's Inc. reported mixed Q2 2024 earnings with a revenue miss and lowered its annual guidance due to a challenging consumer environment. Sales were down 3.8% year-over-year, and the company plans to close more stores than previously estimated. Macy's stock fell 8.62% in premarket trading.

Portfolio Pulse from Vandana Singh

August 21, 2024 | 12:45 pm

INBS

Intelligent Bio Solutions has achieved a significant milestone by installing over 1,000 Intelligent Fingerprinting Drug Screening Readers by June 30, 2024. This marks a 65% year-over-year increase, with sales surging 26% to 407 units in FY 2024.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:36 pm

IVDA

Iveda has integrated its IvedaCare and IvedaAI solutions at Waymark Gardens, a senior living facility in Arizona, to enhance safety and operational efficiency. This integration supports Iveda's subcontract under a $1.032 billion VA contract for remote patient monitoring.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:32 pm

NAOV

NanoVibronix (NASDAQ:NAOV) reported a significant improvement in its Q2 financial results, with EPS losses narrowing to $(0.25) from $(0.65) YoY and sales surging to $817 million from $394K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:31 pm

BABA

JD

WMT

Walmart has sold its stake in JD.com, raising $3.6 billion, which led to a significant drop in JD.com's stock price. Jim Cramer praised Walmart's decision and highlighted Alibaba as the only Chinese stock with real liquidity. JD.com faces challenges from domestic competition and regulatory issues.

Portfolio Pulse from Shanthi Rexaline

August 21, 2024 | 12:28 pm

LRHC

La Rosa Holdings Corp. (NASDAQ:LRHC) has acquired its Carolina, Puerto Rico-based franchisee, BF Prime LLC, as part of its expansion strategy. The acquisition introduces a new revenue model in Puerto Rico, with expectations of significant growth in the real estate market. La Rosa aims for $100 million in annualized revenue by 2024, with profitability projected for 2025. Despite these developments, LRHC shares fell by 4.76% premarket.

Portfolio Pulse from Akanksha Bakshi

August 21, 2024 | 12:15 pm

LRHC

La Rosa Holdings has reaffirmed its target of achieving $100 million in annualized revenue as a 2024 exit run rate.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 12:15 pm